Literature DB >> 29450787

A case of small intestinal neuroendocrine carcinoma diagnosed using double-balloon endoscopy with long-term survival.

Seiji Kawano1,2, Yuichi Miyashima3, Yoshio Miyabe3, Yoshinari Kawai3, Toshihiro Murata4, Masashi Uda4, Toshihiro Inokuchi5, Hiroyuki Okada5.   

Abstract

Neuroendocrine neoplasms, including neuroendocrine tumors (NETs) and neuroendocrine carcinomas (NECs), are rare epithelial tumors with a predominant neuroendocrine differentiation. Compared with NETs, NECs have been reported to be rarer and have a poorer prognosis. We present a rare case of small bowel NEC diagnosed using double-balloon endoscopy (DBE) and the long-term survival accomplished via intensive therapy. DBE revealed an ulcerative tumor in the deep jejunum, and biopsy specimens showed large and highly dysplastic tumor cells; immuno-histological synaptophysin and chromogranin A tests were positive, and the Ki-67 index was more than 90%. Partial intestinal resection without complete lymph node dissection was performed and, postoperatively, chemotherapy was administered. The patient was observed for 3 years after chemotherapy, and complete remission was maintained.

Entities:  

Keywords:  Double balloon endosopy; Neuroendocrine carcinoma; Small intestine

Mesh:

Year:  2018        PMID: 29450787     DOI: 10.1007/s12328-018-0834-8

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  11 in total

1.  Neuroendocrine tumor of small bowel.

Authors:  Chiara Martini; Giacomo C Sturniolo; Eugenio De Carlo; Gianluca Tamagno; Pietro Maffei; Roberto Mioni; Roberto Vettor; Mario Lise; Maria Guido; Nicola Sicolo
Journal:  Gastrointest Endosc       Date:  2004-09       Impact factor: 9.427

2.  ENETS Consensus Guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary.

Authors:  Marianne Pavel; Eric Baudin; Anne Couvelard; Eric Krenning; Kjell Öberg; Thomas Steinmüller; Martin Anlauf; Bertram Wiedenmann; Ramon Salazar
Journal:  Neuroendocrinology       Date:  2012-02-15       Impact factor: 4.914

3.  The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (high-grade) extrapulmonary neuroendocrine carcinomas.

Authors:  Jonathan R Strosberg; Domenico Coppola; David S Klimstra; Alexandria T Phan; Matthew H Kulke; Gregory A Wiseman; Larry K Kvols
Journal:  Pancreas       Date:  2010-08       Impact factor: 3.327

4.  A Case of Neuroendocrine Malignant Tumor with Capsule Retention Diagnosed by Double-Balloon Enteroscopy.

Authors:  Jie Chen; Ling Zhang; Wenjun Zhang; Weiqiang Zheng; Duowu Zou; Zhaoshen Li
Journal:  Case Rep Gastroenterol       Date:  2010-02-06

5.  Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): the NORDIC NEC study.

Authors:  H Sorbye; S Welin; S W Langer; L W Vestermark; N Holt; P Osterlund; S Dueland; E Hofsli; M G Guren; K Ohrling; E Birkemeyer; E Thiis-Evensen; M Biagini; H Gronbaek; L M Soveri; I H Olsen; B Federspiel; J Assmus; E T Janson; U Knigge
Journal:  Ann Oncol       Date:  2012-09-11       Impact factor: 32.976

6.  Epidemiological trends of pancreatic and gastrointestinal neuroendocrine tumors in Japan: a nationwide survey analysis.

Authors:  Tetsuhide Ito; Hisato Igarashi; Kazuhiko Nakamura; Hironobu Sasano; Takuji Okusaka; Koji Takano; Izumi Komoto; Masao Tanaka; Masayuki Imamura; Robert T Jensen; Ryoichi Takayanagi; Akira Shimatsu
Journal:  J Gastroenterol       Date:  2014-02-06       Impact factor: 7.527

7.  Role of double-balloon endoscopy in the diagnosis of small-bowel tumors: the first Japanese multicenter study.

Authors:  Keigo Mitsui; Shu Tanaka; Hironori Yamamoto; Tsuyoshi Kobayashi; Akihito Ehara; Tomonori Yano; Hidemi Goto; Hiroshi Nakase; Shinji Tanaka; Toshiyuki Matsui; Mitsuo Iida; Kentaro Sugano; Choitsu Sakamoto
Journal:  Gastrointest Endosc       Date:  2009-06-24       Impact factor: 9.427

8.  Current Trends of the Incidence and Pathological Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in Korea 2000-2009: Multicenter Study.

Authors:  Mee-Yon Cho; Joon Mee Kim; Jin Hee Sohn; Mi-Jung Kim; Kyoung-Mee Kim; Woo Ho Kim; Hyunki Kim; Myeong-Cherl Kook; Do Youn Park; Jae Hyuk Lee; Heekyung Chang; Eun Sun Jung; Hee Kyung Kim; So-Young Jin; Joon Hyuk Choi; Mi Jin Gu; Sujin Kim; Mi Seon Kang; Chang Ho Cho; Moon-Il Park; Yun Kyung Kang; Youn Wha Kim; Sun Och Yoon; Han Ik Bae; Mee Joo; Woo Sung Moon; Dae Young Kang; Sei Jin Chang
Journal:  Cancer Res Treat       Date:  2012-09-30       Impact factor: 4.679

9.  Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system.

Authors:  Tomohiro Yamaguchi; Nozomu Machida; Chigusa Morizane; Akiyoshi Kasuga; Hideaki Takahashi; Kentaro Sudo; Tomohiro Nishina; Kazutoshi Tobimatsu; Kenji Ishido; Junji Furuse; Narikazu Boku; Takuji Okusaka
Journal:  Cancer Sci       Date:  2014-09-06       Impact factor: 6.716

10.  Clinical, pathological and prognostic characteristics of gastroenteropancreatic neuroendocrine neoplasms in China: a retrospective study.

Authors:  Xianbin Zhang; Li Ma; Haidong Bao; Jing Zhang; Zhongyu Wang; Peng Gong
Journal:  BMC Endocr Disord       Date:  2014-07-08       Impact factor: 2.763

View more
  1 in total

1.  Grade 3 Neuroendocrine Tumor (G3 NET) in a Background of Multiple Serotonin Cell Neoplasms of the Ileum Associated with Carcinoid Syndrome and Aggressive Behavior.

Authors:  Francesca Capuano; Oneda Grami; Luigi Pugliese; Marco Paulli; Andrea Pietrabissa; Enrico Solcia; Alessandro Vanoli
Journal:  Endocr Pathol       Date:  2018-12       Impact factor: 3.943

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.